Therapeutic cancer vaccines have been showing promise in central nervous system diseases. CureVac recently confirmed the safety of its messenger ribonucleic acid (mRNA) vaccine, CVGBM, in glioblastoma in a Phase I clinical trial. Immunomic Therapeutics and IM Biologics have also taken up the challenge of developing cancer vaccines for brain tumors.

Cancer vaccines are therapeutic vaccines that treat cancer by administering cancer cell antigens to patients and activating the immune system rather than prevention vaccines. Like conventional vaccines, cancer vaccines also work with the same mechanism of action, activating the body’s immune response and inducing immunogenic cell death. Major pharmaceutica